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Tai Chi for Reducing Dual-task Gait
Variability, a Potential Mediator of Fall Risk
in Parkinson’s Disease: A Pilot Randomized
Controlled Trial
Gloria Vergara-Diaz, MD1, Kamila Osypiuk, MS2,
Jeffrey M Hausdorff, PhD3,4,5,6,7, Paolo Bonato, PhD1, Brian J Gow, BS2,
Jose GV Miranda, PhD1, Lewis R Sudarsky, MD8, Daniel Tarsy, MD9,
Michael D Fox, MD9,10, Paula Gardiner, MD11, Cathi AThomas, MS12,
Eric A Macklin, PhD10, and Peter M Wayne, PhD2
Abstract
Objectives: To assess the feasibility and inform design features of a fully powered randomized controlled trial (RCT)
evaluating the effects of Tai Chi (TC) in Parkinson’s disease (PD) and to select outcomes most responsive to TC assessed
during off-medication states.
Design: Two-arm, wait-list controlled RCT.
Settings: Tertiary care hospital.
Subjects: Thirty-two subjects aged 40–75 diagnosed with idiopathic PD within 10 years.
Interventions: Six-month TC intervention added to usual care (UC) versus UC alone.
Outcome Measures: Primary outcomes were feasibility-related (recruitment rate, adherence, and compliance). Change in
dual-task (DT) gait stride-time variability (STV) from baseline to 6 months was defined, a priori, as the clinical outcome
measure of primary interest. Other outcomes included: PD motor symptom progression (Unified Parkinson’s Disease Rating
Scale [UPDRS]), PD-related quality of life (PDQ-39), executive function (Trail Making Test), balance confidence (Activity-
Specific Balance Confidence Scale, ABC), and Timed Up and Go test (TUG). All clinical assessments were made in the
off-state for PD medications.
Results: Thirty-two subjects were enrolled into 3 sequential cohorts over 417 days at an average rate of 0.08 subjects per
day. Seventy-five percent (12/16) in the TC group vs 94% (15/16) in the UC group completed the primary 6-month follow-up
assessment. Mean TC exposure hours overall: 52. No AEs occurred during or as a direct result of TC exercise. Statistically
nonsignificant improvements were observed in the TC group at 6 months in DT gait STV (TC [20.1%] vs UC [0.1%] group
[effect size 0.49; P ¼ .47]), ABC, TUG, and PDQ-39. UPDRS progression was modest and very similar in TC and UC groups.
Conclusions: Conducting an RCT of TC for PD is feasible, though measures to improve recruitment and adherence rates
are needed. DT gait STV is a sensitive and logical outcome for evaluating the combined cognitive-motor effects of TC in PD.
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Introduction
Parkinson’s disease (PD) is one of the most common
neurodegenerative disorders.1,2 While primarily charac-
terized by motor symptoms, such as rigidity, tremor,
bradykinesia, and postural imbalance,2 PD is also asso-
ciated with a number of non-motor symptoms (eg,
reduced cognitive function and depression) which
together lead to reduced ability to accomplish functional
tasks, increased fall risk, and a reduced quality of life.3
Gait disturbances in particular are a prominent clin-
ical manifestation of PD and are among its most dis-
abling symptoms.4 In healthy individuals, motor
performance and gait health depends on the interaction
between automatic (unconscious) and volitional (cogni-
tive) control of movement.5 In PD, the early and prefer-
ential loss of dopamine leads to diminished automatic
and increased cognitive control of movements that
include frontal lobe circuitry.6,7 Consequently, individ-
uals with PD need to handle and sustain a larger cogni-
tive load to execute motor tasks.6,8–11
The ability to walk while simultaneously performing
an unrelated cognitive task, referred to here as cognitive
dual tasking (DT), is essential to many activities of daily
living. Such DT interferes with volitional postural con-
trol, a particular problem in PD where automaticity of
gait is already impaired.8,9 In addition to reducing gait
speed, DT in PD has been shown to increase gait vari-
ability,12 a marker of instability and fall risk.13,14
Measures of gait variability during DT are also asso-
ciated with PD progression8,9 and are sensitive to thera-
peutic interventions.15,16
Tai Chi (TC) is a multicomponent mind-body exercise
that is growing in popularity with demonstrated benefits
for multiple aspects of physical and cognitive health. TC
improves postural control in general17,18 and shows
promise as an intervention for reducing the risk of falls
and treating PD symptoms specifically. TC integrates
balance, flexibility, and neuromuscular coordination
training with a number of cognitive components––
including heightened body awareness, focused mental
attention, imagery, multitasking (cognitive-motor and
motor-motor), and planned and goal-oriented train-
ing––which together may result in benefits to PD
beyond conventional exercise.19
A recent meta-analysis supports a benefit of TC for
reducing falls and improving balance for individuals with
PD.20 One large-scale trial included in this meta-analysis
demonstrated that, for mid- to later-stage PD patients
evaluated while on PD medications, TC was superior to
both resistance training and low-intensity stretching for
outcomes related to fall risk, balance, and multiple
domains of physical function.21 However, it is not
known if TC’s impact on fall reduction and postural
control, in this and other studies, is mediated by an
improved ability to maintain healthy stride dynamics
and cognitive-motor integration during DT. In addition,
nearly all studies to date have evaluated the impact of
TC while participants were on PD medications, in con-
trast to the off-medications state that allows a more
direct measure of pathology.20 Moreover, very few stu-
dies have evaluated the impact of TC on newly diag-
nosed or early stage PD progression. Better
understanding of the motor and cognitive processes
through which TC alters gait and balance, especially
assessed in the practically defined off-medication state
in earlier stage PD patients, could better help inform
the therapeutic potential of TC and contribute to the
development of biomarkers and therapeutic targets for
integrative PD treatments.
To inform the feasibility and design features of a fully
powered RCT evaluating the effects of TC on DT stride
time variability (STV) in early- to mid-stage PD and
assessed in the off-medication state, this pilot study
addressed two primary aims: (1) To assess the feasibility
of recruiting and retaining individuals with PD into a 6-
month RCT of TC exercise; and (2) to collect prelimin-
ary data on the efficacy of TC in reducing DT STV to
inform sample size requirements for a future trial.
Materials and Methods
Overview of Study Design
We employed a 2-arm waitlist RCT. A total of 32 par-
ticipants with idiopathic PD, aged 40–75, were rando-
mized 1:1 to 6 months of TC training in addition to
usual healthcare (TC group) or to usual healthcare
alone (UC group). A permuted-block randomization
scheme with randomly varying block sizes was utilized.
Primary staff overseeing assessment and analysis of gait-
related and functional outcomes were blinded to treat-
ment assignment. Since this was a pilot study, the sample
size calculation was selected to provide adequate preci-
sion in estimating feasibility. We aimed to identify the
most sensitive gait parameter to measure in a future
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RCT. Our primary clinical outcome was change in DT
gait variability evaluated from baseline to 6 months.
A battery of secondary outcomes included motor and
non-motor function assessments. The institutional
review board at Brigham and Women’s Hospital
approved this study (2013P002343). The trial was regis-
tered at ClinicalTrials.gov (NCT02418780). Our prelim-
inary findings are reported following guidelines in the
extension of CONSORT statement for randomized
pilot and feasibility trials.22
Study Participants
Participants were recruited from Boston area neurology
practices and PD support groups between March 2014
and August 2015. Individuals were eligible if they were
recently diagnosed with idiopathic PD (410 years) and
had limited disease progression (Modified Hoehn and
Yahr [H–Y] stages 1–2.5);23 40–75 years of age; and will-
ing to undergo baseline and follow-up testing while off
PD-related medication for 12 h. Individuals were
excluded for the following reasons: diagnosis of atypical
parkinsonism; history of major neurological or psychi-
atric disease, orthopedic impairment, or other disease
that could likely contribute to a gait disturbance; any
severe, chronic condition or acute medical event for
which participation in exercise programs was contraindi-
cated; history of deep brain stimulation or other brain
surgery; or significant TC experience (>6 months train-
ing in past 2 years). Written informed consent was
obtained from all participants.
Interventions
Participants randomized to the TC group received
6 months of training. The PD-specific TC program
was adapted from protocols used in prior study
populations with balance and gait impairments,24,25
heart failure,26 and chronic obstructive pulmonary dis-
ease.27 The program targeted the symptoms of
individuals with relatively early-stage PD and included
balance, flexibility, agility, and moderate aerobic
training combined with training in multiple cognitive
components (mindfulness, focused attention, DT, and
mindful breathing). Training included 2-person inter-
active exercises. Meditative music was played in all
classes. Table 1 outlines the specific exercises included
in the protocol.
Classes took place at Brigham and Women’s Hospital
(Cohorts 1 and 2) and Boston Medical Center (Cohort
3). Participants were asked to attend 2 classes per week
on average over the 6-month study. They were also asked
to practice a minimum of 60min per week outside of
class, using a provided instructional DVD. Class attend-
ance was recorded by instructors. Participants recorded
Table 1. Description of Parkinson’s Disease Specific Tai Chi
Program.
Week Activities
Approximate
Duration
(in Minutes)
1–2 Check-in 2
Tai Chi warm-up exercises 38
Tai Chi pouring
Tai Chi swinging and drumming
the body
Standing meditation
Hip circles
Spiral lower extremity joints
Stretching arms and flanks
Fountain
Washing with Qi from the heaven
Renewing the body with the
breath
Introduction to Tai Chi
Movement #1
15
Raising the power
Tai Chi cool-down exercices 5
Self-massage and meridian tapping
Washing with Qi from heavens
3–8 Check-in 2
Tai Chi warm-up exercises 18
Review and practice Tai Chi
Movement #1
5
Learn and practice Tai Chi
Movements #2 and #3
30
Push and withdraw
Wave hands like clouds
Tai Chi cool-down exercices 5
9–12 Check-in 2
Tai Chi warm-up exercises 13
Review and practice Tai Chi
Movements #1–3
15
Learn and practice Tai Chi
Movements #4, #5, #6
25
Grasp the sparrow’s tail
Cross hands
Golden rooster stands on one leg
Tai Chi cool-down exercices 5
13–24 Check-in 2
Tai Chi warm-up exercises 13
Review and practice Tai Chi
Movements #1–6
30
Agility and interactive Tai Chi
training
10
Tai Chi cool-down exercices 5
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frequency and duration of home practice using self-
report logs collected monthly by study staff.
Procedures
All study assessments were performed at the Motion
Analysis Laboratory at Spaulding Rehabilitation
Hospital. Outcomes were assessed at baseline, 3
months (to study progression), and 6 months (ie, after
the completion of 6 months of training). All study par-
ticipants were asked to withhold anti-Parkinsonian
medications for 12 h prior to testing visits.
Outcomes Assessed
Feasibility and safety (Aim 1). In order to assess the feasibil-
ity of recruiting and retaining individuals with PD into a
6-month RCT of TC exercise, the following data were
collected: Recruitment rate (number of subjects screened
vs enrolled and average number enrolled per day), adher-
ence to TC protocol (number of classes attended per
subject and self-reports of hours of home-based exer-
cise), compliance with the assessment protocol (number
of study visits completed per subject), and adverse events
(AEs) reported during the study.
Clinical (Aim 2). To select the gait parameters most sensi-
tive to TC, steady-state gait was assessed during 90 s of
continuous over-ground walking at normal preferred
speed, with and without the addition of DT challenges.
Change in DT STV from baseline to 6 months was
defined, a priori, as the clinical outcome measure of pri-
mary interest. Gait was assessed along a 15-m path that
was wide enough to enable smooth turning. We used 2
cognitive DT challenges: serial subtractions (counting
backwards by 3’s (DTcount)) and the Star Movement
Task (DTstar) (a visuospatial task that requires subjects
to visualize a star moving among 4 imaginary
boxes arranged in a square according to verbal instruc-
tions and report the star’s final location).28 Stride
times was assessed using 2 force sensing resistors
(model FSR 402, Interlink Electronics, Westlake
Village, CA, USA) placed under the heel and the
toe and recorded with the SHIMMERTM sensing
platform (Dublin, Ireland).29
Stride times were calculated for each gait cycle as the
time between initial heel strike of one foot and the sub-
sequent heel strike of that same foot. STV was calculated
from the stride time time-series as the coefficient of vari-
ation (CV, 100 multiplied by the SD of the stride times
divided by the mean of each subject’s stride times). DT
costs were calculated using both absolute and propor-
tional measures. Absolute DT costs (Abs. DT) were cal-
culated for each participant as the difference in walking
speed or STV between undisturbed single-task walking
(ST) and DT walking. Proportional DT costs (% DT)
were calculated for each participant’s walking speed or
STV as follows: 100 ([DT – ST]/ST). Both the number
and the accuracy of serial subtractions during DTcount
and the accuracy of the star movement during DTstar
were recorded.
PD motor symptom progression was assessed with the
27 items of the UPDRS motor subscale (part 3); scores
range from 0 to 108 (higher score indicates greater motor
disability).30 Testing was conducted by a clinician with
expertise in PD assessment. PD-related quality of life
(QoL) was assessed using the PDQ-39, a 39-item self-
report assessment of PD-specific health-related QoL
over the last month (higher score indicates worse
QoL).31 Executive cognitive function was assessed
using the Trail Making Test (TMT). TMT A (number
sequence only) assesses visual search. TMT B (alter-
nating numbers and letters) evaluates executive control
(lower score indicates higher executive function).32,33 The
ratio between TMT B and A more accurately assesses
executive function since it corrects for processing
speed.33 Balance confidence was assessed using the
Activity-specific Balance Confidence Scale (ABC)
(higher score indicates greater self-confidence in physical
functioning).34 The Timed Up and Go Test (TUG)35 was
used to assess mobility. The average of 3 attempts of the
time required to rise from a chair, walk 3m, return, and
sit down was collected (faster times indicate better
mobility).
Data Synthesis and Statistical Analysis
Pre-specified hypotheses related to feasibility (Aim 1). Feasibility
was evaluated with respect to 4 attributes: recruitment,
retention, attendance, and adherence. Recruitment suc-
cess was evaluated by completion of planned enrollment,
defined as randomization into the trial, and by evidence
of an adequate rate of enrollment. Specifically, we tested
the hypothesis that our expected rate of enrollment was
noninferior to a rate of 0.25 randomizations per day
during active recruitment based on a one-sided 90%
lower confidence bound assuming Poisson-distributed
enrollments per day. With our planned sample size
of n¼ 20 per cohort and 2 cohorts, the study would
have greater than 90% power if our true expected rate
was at least 0.37 per day, equivalent to completing
recruitment in 81 days for each cohort. Retention,
attendance, and adherence were quantified by the pro-
portion of subjects who completed the trial, the propor-
tion of TC classes attended, and the proportion of
assigned home practice completed, respectively. Study
completion rates were compared between treatment
groups by relative risk of noncompletion and tested by
Fisher’s exact test. Minimal adequate attendance and
adherence were defined as attending at least 70% of
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TC classes and completing at least 70% of home practice
sessions, respectively. We tested noninferiority of
expected rates of attendance and adherence assuming
beta-binomial distributed events. Noninferiority to our
target attendance and adherence rates were evaluated
using one-sided 90% lower confidence bounds on the
estimated average rates across participants. Confidence
bounds and one-tailed P values for testing noninferiority
for all 4 measures of feasibility were obtained using max-
imum likelihood estimates of each rate and its standard
error using a log link function.
Analysis of primary and secondary outcomes (Aim 2). Efficacy
outcomes were compared between TC and UC using
repeated-measure ANOVA models with shared baseline,
fixed effects of visit and treatmentpost-baseline visit
interaction, and unstructured covariance among
repeated participant-specific observations over the 3
visits. The Wald statistic from a linear contrast over
the treatment visit interaction testing 6-month treat-
ment-dependent response was used to test for any
effect of TC and as a criterion for selecting efficacy out-
comes that are potentially sensitive to TC. Two stages of
selection were used, first to select the most responsive DT
STV outcome (counting vs star) based on effect sizes.
Effect sizes were calculated as the estimated treatment
difference in 6-month change divided by the standard
deviation of 6-month change among control group par-
ticipants. A second stage of selection ranked additional
gait-related and non–gait-related outcomes to identify the
best measure for evaluating the efficacy of TC in a future
trial. Selection of the optimal outcome was guided by
consideration of clinical relevance and participant burden.
Data were analyzed using MATLAB (Mathworks,
Natick, MA) and SAS (version 9.4 SAS Institute, Cary, NC).
Results
Participant Flow
A CONSORT flowchart is shown in Figure 1.
Baseline Characteristics
Participants randomized to TC or UC groups were
relatively well matched at baseline (see Table 2).
Figure 1. Flow of participants in randomization trial of subjects with Parkinson’s disease.
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Mean (SD) age was 63.8 6.3 years, and 50% of par-
ticipants were female. Mean PD duration was 2.9 2.3
years. Seventy-five percent of participants were H–Y
stage 2. Mean UPDRS motor score was 23.5 9.5,
with slightly worse function in the TC group.
Feasibility Outcomes (Aim 1)
Recruitment. Participants were recruited over a 15-month
interval. Recruitment was slower than expected.
Ultimately, 32 subjects with idiopathic PD were enrolled
into 3 sequential cohorts over 417 days at an average rate
of 0.08 subjects per day (95% CI: 0.05–0.11, P> .99 for
noninferiority to a rate of 0.25; recruitment rates for the
3 cohorts were 0.12, 0.09, and 0.04 subjects per day,
respectively). We terminated our recruitment before
achieving 40 subjects due to a combination of lower
than expected recruitment rates and funding constraints.
Retention, attendance, and adherence. Of the 32 subjects
randomized, 75% (12/16) in the TC group versus 94%
(15/16) in the UC group completed the primary 6-month
follow-up assessment (relative risk among TC subjects of
early termination or loss to follow-up¼ 1.25, 95% CI:
0.88–1.94, P¼ .33). Of those randomized to the TC
group, 3 officially withdrew participation due to unre-
lated medical reasons. One was lost to follow-up.
Another completed all follow-up study visits but stopped
attending classes after only 5 classes and did not do any
home practice. One UC subject withdrew consent. Of the
16 subjects randomized to TC, attendance of the 48
scheduled TC classes ranged from 4% to 92% with a
median of 68%. The estimated percentage of TC classes
attended was 57% (95% CI: 44%–70%, P¼ .98 for non-
inferiority to 70%). Among the 12 TC subjects who com-
pleted the study, class attendance ranged from 10% to
92% with an estimated percentage of TC classes
attended of 70% (95% CI: 57%–80%, P¼ .51).
Including 2 TC subjects with missing home practice
data who had withdrawn from the study, 75% (12/16)
completed at least 70% of home practice (95% CI:
48%–93%, P¼ .45 for non-inferiority to 70%).
Table 2. Baseline Characteristics of Subjects by Groups.
Tai Chi Usual Care
(n¼ 16) (n¼ 16)
Age (years), AVG SD 65.7 3.86 62 7.77
Gender, n (%)
Male 9 (56.3%) 7 (43.8%)
Female 7 (43.8%) 9 (56.3%)
Race, n (%)
White 16 (100%) 16 (100%)
Ethnicity, n (%)
Non-Hispanic 16 (100%) 14 (87.5%)
Unknown 2 (12.5%)
Education (years), AVG SD 20.2 8.46 17.56 2.31
Employment status, n (%)
Employed 9 (56.3%) 10 (62.5%)
Retired 6 (37.5%) 5 (31.3%)
Unemployed 0 (0.0%) 1 (6.3%)
Disabled 1 (6.3%) 0 (0.0%)
BMI (kg/m2), AVG SD 28.2 5.52 26.9 5.82
Physical activity status (0–10 scale), AVG SD 4.1 1.93 4.31 2.73
Duration of disease (years), AVG SD 2.9 2.38 2.9 2.20
Taking PD Meds, n (%) 14 (87.5%) 15 (93.8%)
Hoehn and Yahr stage, n (%)
2 11 (68.8%) 13 (81.3%)
2.5 5 (31.3%) 3 (18.8%)
UPDRS Motor Score (0–108 scale), AVG SD 26.38 9.64 20.63 8.69
Abbreviation: AVG, average; BMI, body mass index; PD, Parkinson’s disease; SD, standard deviation; UPDRS, Unified Parkinson’s
Disease Rating Scale.
Continuous variables: values provided are mean standard deviation.
Categorical variables: values provided are absolute frequency (relative frequency).
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Average amount of home practice was 30 h among the 14
TC subjects with data; among the 12 subjects who com-
pleted the study (not withdrawn or lost to follow-up),
average amount of home practice was 32 h. Mean total
TC exposure hours were 52 and 67 for all subjects and
just completers, respectively.
Adverse events. No AEs occurred during or as a direct
result of TC exercise. Over the course of the study, 12
AEs were reported by 9 subjects (4 in TC, 5 in UC
group); all AEs were unrelated to the study and included:
back pain (n¼ 5), falls/injuries (n¼ 4), illness (n¼ 2),
and pain (n¼ 1).
Clinical Outcomes (Aim 2)
We analyzed gait related data of 16, 14, and 12 subjects
at baseline, 3, and 6 months, respectively, in the TC
group, and 16, 13, and 13, respectively, for the same
time periods in the UC group.
STV increased with the addition of a DT challenge in
both the TC and UC groups (Table 3). Repeated-
measure ANOVA models adjusting for variation due
to baseline score, age, gender, and UPDRS score
revealed a statistically nonsignificant trend over 6
months towards a greater reduction in DTcount STV in
the TC (20.1%) versus UC (0.1%) group (effect size
0.49; P¼ .47; Figure 2). Similar patterns were observed
for DTstar STV. Absolute and percent DT cost of STV
also trended towards being lower in the TC group, but
the differences were not statistically significant. A per-
protocol analysis of DTcount STV limited TC participants
who were at least 50% compliant with class attendance
and home practice resulted in an effect size similar to the
estimates including all participants (EF¼ 0.47; P¼ .55).
Compared to undisturbed walking, gait speed
decreased during DT walking in both groups (Table 3).
Group differences in this outcome, as well as derived
differences in absolute and percent DT cost, were small
and not statistically significant (see Table 3).
Performance on both cognitive tasks was comparable
overall between groups. Accuracy of serial subtractions
was equivalent while seated and during walking (93%
and 94% in TC and UC, respectively). Accuracy of the
Star Movement Task decreased slightly during gait (86%
and 87% in TC and UC, respectively) compared to
seated (95% and 90% in TC and UC, respectively).
Statistically nonsignificant trends at 6 months indicat-
ing greater improvements in the TC versus UC group
were observed in PD-related QoL, ABC, and the TUG.
Both groups improved slightly in TMT, but the results
were not statistically significant. Repeated-measure
ANOVA models adjusting for variation due to baseline
score, age and gender revealed that UPDRS progression
was modest and very similar in TC and UC groups.
Discussion
The present study aimed to assess the feasibility of con-
ducting an RCT of TC training for individuals in the
early stages of PD progression and assessing outcomes
targeting cognitive-motor interdependence in the off-
medication state. Based on the observed recruitment,
adherence, and retention rates, a future RCT fully pow-
ered to evaluate the effectiveness of TC for PD patients
would likely be achievable with modifications to improve
recruitment and adherence rates. Furthermore, our abil-
ity to detect small clinical differences between the TC
and usual care group allowed us to identify promising
markers of improvement to use in future trials of this
intervention.
Outcomes
A recent meta-analysis based on 15 RCTs supports a
benefit of TC for reducing falls and improving balance
for individuals with PD.20 However, the cognitive and
motor mechanisms underlying these benefits remain
poorly understood. A primary motivation for this pilot
study was to lay the foundation for exploring the
hypothesis that TC reduces the impact of a cognitive
distraction on gait steadiness in PD (ie, DT gait STV).
Studies have shown that DT STV is a promising discri-
minating metric for predicting falls and understanding
PD disease progression36,37 and prior TC research has
demonstrated improvements in DT STV in healthy
older adults following 6 months of TC training.36
However, prior studies of TC for individuals with PD
have not evaluated the impact of TC on DT STV in
this population. While our study was not adequately
powered to assess the efficacy of TC on DT gait STV,
we observed a clear trend towards greater reductions in
DTcount STV in the TC group when compared to the
wait-list control. This finding supports that STV is a
good outcome for evaluating cognitive-motor improve-
ment in future studies, potentially informing the mech-
anism underlying improved postural control following
TC training.
The prevailing neuropsychological theory used to
explain the difficulties of performing 2 concurrent cog-
nitive tasks posits that each task competes for shared
brain resources.38 The extent to which performance is
disrupted in one or both tasks thus depends upon
resource availability,39 resource allocation,40,41 and/or
the speed of information processing.42 Therefore, the
observation that performing a cognitive task while walk-
ing disrupts locomotor control suggests that these tasks
compete for shared resources involving specific neural
networks. Age- and/or Parkinson’s-related increases in
the cognitive task costs on locomotor control may arise
in part from reduction in cortical resources, faulty allo-
cation of resources,43 or slowing of the speed at which
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information is processed.41 Future studies that combine
clinical DT gait assessments with targeted neuroimaging-
based brain activation patterns and resting state neural
network connectivity would significantly contribute to
evaluating the neural basis underlying TC’s impact on
cognitive-motor interactions in PD.
Other outcomes we observed to be sensitive to TC and
to be considered in future trials include TUG and ABC.
There was a trend toward the TC group improving in the
TUG, although our observed magnitude of decrease was
smaller than that found in a previous large RCT of TC
training in PD.21 Statistically nonsignificant positive
trends were also observed in ABC. Baseline scores for
both these outcomes indicated relatively low levels of
impairment compared to prior studies, which may be
due to our population being less progressed in their
PD. This, in turn, may have led to a potential ceiling
effect precluding larger improvements. UPDRS scores
worsened in both groups, as is expected over 6 months
of PD progression. However, scores increased less in the
TC group, suggesting potential slowing of motor symp-
tom progression with TC training. In contrast, there
were no observed trends in executive function evaluated
with the TMT. Future studies should consider a wider
battery of tests to evaluate executive and other domains
of cognition.
Lessons Learned and Design of Future Trial
A total of 98 individuals were assessed for eligibility,
demonstrating that recruitment efforts were successful
in reaching people with PD and that the study was of
interest. Nearly half (48%) of those screened did not
meet eligibility criteria (Figure 1). Obstacles to commit-
ment included class location, class start time, or a com-
bination of both. Enrollment rates for a larger RCT
could likely be enhanced by offering participants a
choice of class site and start time. A longer recruitment
window and use of multiple recruiting centers would also
facilitate recruitment of a larger sample size.
Power calculations based on preliminary findings sug-
gest that if the effect of TC on DTcount STV is as
observed in this study (a magnitude associated with a
clinically meaningful reduction in falls4,44), then a
sample size of 134 (67 per group) would provide 80%
power for a future trial when testing at 2-tailed P< .05.
This magnitude of effect might be further increased by
improved TC compliance and a longer exposure period.
As the optimal dose of TC for PD is not known, it is
possible that a longer period of practice may be neces-
sary to observe clinically meaningful improvements. To
sustain adherence over a longer intervention period, the
use of incentives could be considered, as employed in
other longer-term TC studies.45 Enhancement of the
effect size of TC may also require adjustments to the
T
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training protocol. The optimal intensity level of exercise
for individuals with PD is currently under investigation;
however, some evidence suggests that higher intensity
exercise might be beneficial.46–49 As our study partici-
pants were in the early stages of PD and relatively high
functioning, perhaps they would have benefited from a
more challenging training program. A future TC regimen
might include a greater emphasis on, and an earlier intro-
duction of, challenging training elements such as greater
emphasis on single leg stance, dynamic agility, varying
movement tempos, and adding additional sequences
requiring more complex cognitive-motor coordination.50
While we conducted testing of subjects in the off state,
prior studies of TC for PD have conducted testing of
subjects while on their PD medications, which could
potentially account for the differences in results.
Testing in both on- and off-medication state in future
studies should be considered.
To control for attention and expectation associated with
the intervention, a future study could include an additional
active control arm. For example, seated stretching has been
shown to be a relatively inert comparison intervention in
this population21 and might be considered.
Limitations
We recognize several limitations. The sample size of both
groups was small and treatment duration was relatively
short. Due to the nature of the intervention, participants
could not be blinded to their treatment assignments,
introducing bias and a potential impact of expectation
on outcomes. The study also did not include an active
control, which limits our ability to interpret the effects of
TC and identify potential mechanisms.
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